, 10) because it had been shown to be indistinguishable from that of beef.
11)
Kasai et al., however, reported that the fluorescent base from rat liver tRNA Phe was b-hydroxywybutine (2) on the basis of the MS spectral data as well as the negative coloring test for the hydroperoxy group. 12) Those authors proposed that 3 might be an artifact formed during storage of the sample of 2 and suggested that the base from wheat germ tRNA Phe was also 2. Notwithstanding that report, Mochizuki et al. preferred 3 for the fluorescent base isolated from the aquatic fungus Geotrichum candidum tRNA Phe . 13) Wiewiórowski's group also reported that the base from tRNAs Phe of wheat germ, yellow lupine seeds, and maize seeds was 3. They described 3 as very unstable and found that it decomposed to 2 and 1 14) : The stability observed for 2 and 3 contradicted that reported by Kasai et al. 12) Although we achieved the synthesis of (aS,bR)-and (aS,bS)-2 as the most probable alternatives for the base isolated from rat liver tRNA Phe , 3, 15, 16) the lack of a sample of the base from the tRNA Phe has hampered its structural determination. In the present investigation, we isolated the corresponding nucleoside from rat liver for the first time and determined its structure to be (aS,bS)-11, the first synthesis of which is also described. A preliminary communication of this work has been published. 17, 18) 
Results and Discussion
Synthesis The synthesis of the bases (aS,bR)-and (aS,bS)-2 has been accomplished by OsO 4 oxidation of the olefin 4 followed by separation of the resulting diastereomers 5 and 7 and hydrogenolysis through the cyclic carbonates 6 and 8, as shown in Chart 1. 3, 15, 16) In the present study, we first examined the applicability of this reaction sequence to the nucleoside level. Thus the Heck reaction between 2Ј,3Ј,5Ј-tri-O-acetyl-7-iodowyosine (9) 19) and (Ϯ)-2-[(methoxycarbonyl)amino]-3-butenoic acid 20) was conducted according to the procedure reported for the synthesis of 3-b-D-ribofuranosylwybutine (12) . 19) The product was treated with Me 3 SiCHN 2 to give a mixture of diastereomers 10. This was subjected to OsO 4 oxidation followed by cyclocondensation with triphosgene, catalytic hydrogenolysis, purification by preparative TLC, and deprotection to afford a mixture of four diastereomers 11, as shown in Chart 2. These were separated by HPLC. Two were (aS,bR)-and (aS,bS)-11, of which unambiguous syntheses are described below. The structures of the others [(aR,bS)-and (aR,bR)-11] were assignable by comparison of the 1 H-NMR patterns of their amino acid moieties with those of (aS,bR)-and (aS,bS)-11. Assuming that 2 is the correct two-dimensional expression of the structure of the hypermodified base of rat liver tRNA Phe , one of the four diastereomers 11 is likely the correct structure of the corresponding nucleoside. We preferred (aS,bR)-11 and (aS,bS)-11 as the most probable alternatives because structurally related wybutosine (12) from yeast tRNA Phe had been determined by us to have the (aS) configuration. 2) Because it is difficult to obtain stereochemically pure (aS)-10 in a large quantity, 19) we selected 13 2) as a key intermediate for the stereospecific synthesis of (aS,bR)-and (aS,bS)-11. OsO 4 oxidation of the olefin 13 in the presence of N-methylmorpholine N-oxide in acetone-phosphate buffer (pH 6) at room temperature, followed by HPLC on silica gel afforded the diols 14 and 16 in 51% and 30% yields, respectively. The configurations of these compounds were assignable by comparison of their 1 H-NMR spectra with those of the bases 5 and 7.
3) Treatment of the major isomer 14 with an excess of triphosgene in CH 2 Cl 2 in the presence of pyridine at 0°C afforded the cyclic carbonate 15 in 80% yield. Catalytic hydrogenolysis of 15 over Pearlman's catalyst afforded the bhydroxy compound 17 in 28% yield together with the dideoxy compound 18
2) (23%). The analogous concomitant formation of the dideoxy compounds has already been recognized in the reaction of the model compound (Ϯ)-19 3, 16) and in the reactions involved in Charts 1, 2. As illustrated in Chart 4, hydrogenolysis of (Ϯ)-19 should produce the intermediate 20. While hydrolysis of the hydrogen carbonate 20 would provide the desired monohydroxy compound 21, elimination of H 2 CO 3 followed by hydrogenation would form the dideoxy compound 23 through the olefin 22. Analogous examples of the formation of saturated compounds and olefins have already been reported for the electrochemical reduction of cyclic carbonates of meso-hydrobenzoin, (Ϯ)-hydrobenzoin, and (E)-2,3-diphenylbutane-1,2-diol. 21) Although the undesirable dideoxygenation of (Ϯ)-19 could be suppressed to some extent by the use of Pt instead of Pd-C, 16) the Pt catalyst was found in the present investigation to be inferior in view of reproducibility for hydrogenolysis of 15. Deprotection of 17 was accomplished by treatment with Bu 4 NF in aqueous THF in the presence of pyridine at room temperature 22) without cleaving the extraordinarily labile glycosyl bond to provide the desired nucleoside in 86% yield. The correctness of the assignment of the structure (aS,bR)-11 to this product was established by its hydrolysis with 0.1 N aqueous HCl, leading to optically pure (aS,bR)-2. The 1 H-NMR [(CD 3 ) 2 SO or (CD 3 ) 2 CO] spectral patterns of signals arising from the side chains of these two compounds closely resemble each other. This is also the case with the 1 H-NMR spectra of 17 and (R*,S*)-1-benzyl-b-hydroxy-a-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-4,9-dihydro-1H-imidazo[1,2-a]purine-7-butanoic acid methyl ester [(Ϯ)-24] 16) measured in CDCl 3 , as shown in Table 1 . However, (aS,bR)-2 shows a somewhat different 1 H-NMR spectrum from that of 17 in CDCl 3 ( Table 1) , suggesting that N(1)-H of (aS,bR)-2 affects the conformation of its side chain through hydrogen bonding in this solvent.
Contrary to the successful conversion of the diol 14 into the carbonate 15, the minor isomer 16 with (aS,bR,gR) configurations did not produce the cyclic carbonate 26 at all upon treatment with triphosgene in a manner similar to that employed for the preparation of 15. The starting material 16 was recovered in ca. 80% yield. This is an unbelievably strange result in view of the positive reaction of the base 7 3) (Chart 1) having the same configurations and the reaction of the (aS,bR,gR)-nucleoside involved in the reaction sequence shown in Chart 2. The latter case indicated what should be done to obtain the desired carbonate 26. When a mixture of 16 and 14, accessible in 91% yield in a ratio of 1 : 2 in the above OsO 4 oxidation of 13, was subjected to the reaction with triphosgene, 26 was obtained as a mixture with 15 in a ratio of 1 : 2.9. However, 26 was not formed when 16 was added after the reaction of 14 with triphosgene was completed even in the presence of excess reagents. These results suggest that an intermolecular interaction between the side chains of 14 and 16 is important for the cyclocondensation of 16. Although separation of the mixture of 15 and 26 was difficult, 16 underwent cyclocondensation as well with triphosgene in the presence of the base 5 having the (aS,bS,gS) configurations, giving a mixture of the carbonates (26 and 6) as shown in Chart 5. Compound 26 was easily obtained from this mixture by flash chromatography in 57% yield. Hydrogenolysis of 26 using Pearlman's catalyst afforded the monohydroxy compound 27 in 39% yield together with the dideoxy compound 18 (19%). As the two diastereomers 17 and 27 can be separated by flash chromatography, these were more conveniently obtained by hydrogenolysis of the 1 : 2.9 mixture of 15 and 26 described above in 21% and 8% yields, respectively, based on the olefin 13 (Chart 6). Desilylation of 27 afforded (aS,bS)-11 in 86% yield. Hydrolysis of (aS,bS)-11 produced optically pure (aS,bS)-2 in 98% yield.
It should be noted that the 1 H-NMR spectrum arising from the side chain of the base (aS,bS)-2 in CDCl 3 does not resemble those of (Ϯ)-25 16) and 27. Interestingly, (aS,bS)-2 shows two sets of signals (species 1 and 2 in Table 1 3 . Furthermore, the molar ratio of the two species estimated on the basis of relative areas of the C(6)-Me signals depended on the total concentration, as shown in Table  2 . These results suggest that (aS,bS)-2 molecules associate themselves in part through intermolecular hydrogen bond(s) in CDCl 3 .
Compounds (aS,bR)-and (aS,bS)-11 thus obtained were converted into their tetraacetates-d 12 28 and 29 according to the strategy that we had used to determine the structures of wyosine 1) from torula yeast tRNA and wybutosine (12) 2) from baker's yeast tRNA. Compounds 28 and 29 could be distinguished by comparison of their 1 H-NMR spectra taken in CDCl 3 .
Isolation and Identification of the Minor Nucleoside and Its Base from Rat Liver tRNA We had already determined the structures of wyosine 1) and wybutosine (12) 2) by isolating these nucleosides on a scale of 70-80 mg. To determine how many rats are required for isolation of a comparable amount of the target nucleoside, we first attempted isolation of the corresponding base as a preliminary experiment. Unfractionated tRNA obtained from the livers of ca. 10 rats was subjected to mild acid treatment 23) (pH 2.9 at 40°C for 16 h), and polynucleotides were removed by precipitation with EtOH. The minor base was obtained on a scale of a few micrograms from the soluble part by means of TLC on silica gel. The HPLC behavior of the base thus obtained was identical with that 3) of (aS,bS)-2, and the correctness of its absolute configurations was established by chiral HPLC analysis. Furthermore, the assignable signals appearing in the 1 H-NMR spectrum [(CD 3 ) 2 CO] of this compound corresponded to those of (aS,bS)-2. No trace of wybutine (1) was detected in contrast to the results reported by Kasai et al. 12) It follows that (aS,bS)-2 is unlikely to be an artifact of hydroperoxywybutine (3), because 3 was reported to decompose to 2 and 1.
14) Thus we concluded that the formula (aS,bS)-2 is a complete expression of the hypermodified base of rat liver tRNA Phe . It should be noted that (aS,bS)-2 was stable during storage at room temperature, contrary to the contention of Kasai et al. 12) To isolate the nucleoside on a scale of some 50 mg, we next started with the same grade of tRNA (1 g) obtained from 100 rats. Because this material resisted digestion with nuclease P 1 , it was extracted with aqueous Me 2 CHOH and then with H 2 O. The tRNA in the combined solution was purified by ion-exchange chromatography to give unfractionated tRNA (350 mg). This was partially digested with nuclease P 1 followed successively by reverse-phase column chromatography, complete digestion with nuclease P 1 , dephosphorylation with alkaline phosphatase, and HPLC according to the reported procedure 1, 2) to give the target nucleoside (100 mg). We did not find any trace of wybutosine (12) . The HPLC behavior of the nucleoside was identical to that of (aS,bS)-11 but different from that of the diastereomer (aR,bR)-11, ruling out the 3-b-L-ribofuranosyl structure 30 for this nucleoside because (aR,bR)-11 is the enantiomer of 30. The minor nucleoside thus obtained was converted into the tetraacetated 12 , which was identical to 29 on the basis of MS and 1 H-NMR spectroscopy. Finally the tetraacetate-d 12 of natural origin was treated with MeONa-MeOH and then with dilute aqueous HCl to give the base, the identity of which with (aS,bS)-2 was confirmed by comparison of their HPLC behavior and 1 H-NMR spectra. The structure of the hypermodified nucleoside of rat liver tRNA Phe was hereby determined unambiguously to be (aS,bS)-11. Experimental General Notes Spectra reported herein were recorded on a JEOL JMS-SX102A mass spectrometer, a Hitachi U-3010 spectrophotometer, or a JEOL JNM-GSX-500 NMR spectrometer (measured at 25°C with Me 4 Si as an internal standard unless otherwise stated). CDCl 3 for measurements of small samples was treated with alumina according to the reported procedure.
1) MS measurements were performed by Dr. M. Takani and her associates at Kanazawa University. The optical rotation was measured with a Horiba SEPA-300 polarimeter using a 10-cm sample tube. The HPLC system employed consisted of a Tosoh CCPD pump, an injection valve unit, a UV-8020 detector, and a Chromatocorder 21 integrator or a Waters 6000A pump, a U6K injector, and a model 440 absorbance detector. The following abbreviations are used: brϭbroad, dϭdoublet, ddϭdoublet-of-doublets, dddϭdoublet-of-doublets-of-doublets, ddddϭdoublet-of-doublets-of-doublets-of-doublets, ddtϭdoublet-of-doublets-of-triplets, mϭmultiplet, and sϭsinglet.
Synthesis 20) (191 mg, 1.20 mmol) was added to the mixture, and the whole was stirred at 60-65°C for 8 h. After H 2 O (30 ml) was added, the resulting mixture was brought to pH 3 by the addition of 10% aqueous H 3 PO 4 and extracted with CHCl 3 (2ϫ30 ml). The organic layers were combined and extracted with saturated aqueous NaHCO 3 (3ϫ20 ml). The aqueous layers were combined, brought to pH 3 with 10% aqueous H 3 PO 4 , and extracted with CHCl 3 (4ϫ20 ml). The organic layers were combined, dried over MgSO 4 , and concentrated in vacuo. The oily residue was dissolved in a mixture of MeOH (1 ml) and benzene (4 ml), and 2.0 M Me 3 SiCHN 2 solution in hexane (0.3 ml) was added. The resulting solution was concentrated in vacuo, and the residue was purified by flash chromatography [AcOEt-EtOH (10 : 1, v/v)] to give 10 (115 mg, 23%) as a yellow glass. The diastereomeric mixture thus obtained was dissolved in Me 2 CO (15 ml). After a solution of N-methylmorpholine N-oxide monohydrate (42 mg, 0.31 mmol) in 0.5 M phosphate buffer (pH 6, 15 ml) and a 1.6% (w/v) OsO 4 solution in Me 3 COH (0.4 ml) were added, the mixture was stirred at room temperature for 5 h and then for a further 30 min after the addition of Na 2 S 2 O 5 (57 mg, 0.30 mmol). The resulting suspension was concentrated to half the initial volume and extracted with CHCl 3 (2ϫ20 ml). The organic layers were combined, washed with saturated aqueous NaCl, dried over MgSO 4 , and concentrated in vacuo to leave a colorless glass (109 mg). This was purified by flash chromatography [CHCl 3 -MeOH (10:1, v/v)], providing a colorless glass (57 mg). A portion (20 mg) of this mixture of the diols was treated with triphosgene (18 mg) in CH 2 Cl 2 (2 ml) in the presence of pyridine (0.03 ml) at 0°C for 20 min. The resulting solution was washed successively with H 2 O (3 ml), 5% aqueous citric acid (2ϫ3 ml), and H 2 O (2ϫ3 ml), dried over MgSO 4 , and concentrated in vacuo, leaving a colorless glass (7 mg). A portion (5 mg) of this material was hydrogenated over Pearlman's catalyst (15 mg) in MeOH (4 ml) at 40°C for 2 h. The catalyst was removed by filtration and washed with hot MeOH (50 ml). The filtrate and washings were combined and concentrated in vacuo. The residue was purified by TLC on silica gel [CHCl 3 -MeOH (10 : 1, v/v)] to give a diastereomeric mixture of the monohydroxy compounds (2 mg) as a colorless glass. After a solution of this product in 0.1 M MeONa-MeOH (0.15 ml) was stored at 0°C for 5 min, 0.1 M aqueous NaH 2 PO 4 (0.3 ml) was added at once. The resulting mixture was concentrated in vacuo, and the residue was purified by TLC on silica gel [CHCl 3 -MeOH (5 : 1, v/v)], giving a colorless glass (1 mg). Separation of the diastereomers thus obtained was accomplished by HPLC [LiChrosorb RP18 (7 mm, 250ϫ10 mm) (Merck); MeOH-H 2 O (30 : 70, v/v) at the rate of 5 ml/min] in two portions. The molar ratio of the diastereomers was 1 : 2 : 2 : 1 in the order of elution. The isomer that was eluted the fastest was identical (by comparison of the 1 H-NMR spectrum and HPLC mobility) to the authentic (aS,bS )-11 described below. (aR,bS )- 2) (333 mg, 0.392 mmol) in Me 2 CO (33 ml). The resulting mixture was stirred at room temperature for 4 h and then for a further 30 min after the addition of Na 2 S 2 O 5 (124 mg, 0.652 mmol). The mixture was concentrated to half the initial volume and extracted with CH 2 Cl 2 (3ϫ20 ml). The organic layers were combined, dried over MgSO 4 , and concentrated in vacuo to leave a foam (341 mg). This was dissolved in hexane (4 ml) and the solution was subjected to HPLC [LiChrosorb Si-60 (7 mm, 250ϫ10 mm) (Merck); hexane-CHCl 3 -MeOH (50 : 48 : 2, v/v)] in eight portions, providing (aS,bS ,gS 4 and concentrated in vacuo. The residual foam was dried over P 2 O 5 at 2 mmHg at room temperature for 3 h. This was dissolved in CH 2 Cl 2 (2 ml), and pyridine (0.06 ml, 0.7 mmol) was added. A solution of triphosgene (16 mg, 0.054 mmol) in CH 2 Cl 2 (2 ml) was then added dropwise at 0°C over a period of 3 min, and the mixture was stirred at 0°C for a further 15 min. The reaction mixture was diluted with CH 2 Cl 2 (5 ml), washed successively with H 2 O (5 ml), 5% aqueous citric acid (2ϫ5 ml), and saturated aqueous NaHCO 3 (5 ml), dried over MgSO 4 ]-2-oxo-1,3-dioxolane-4 -acetic Acid Methyl Ester (26) A solution of triphosgene (6 mg, 0.02 mmol) in dry CH 2 Cl 2 (0.6 ml) was added dropwise to a solution of 16 (7.8 mg, 0.0088 mmol), 5 3, 16) (9.0 mg, 0.018 mmol), and pyridine (0.03 ml) in CH 2 Cl 2 (0.6 ml) at 0°C under N 2 over a period of 3 min, and the mixture was stirred at 0°C for a further 15 min. The reaction mixture was diluted with CH 2 Cl 2 (5 ml), washed successively with H 2 O, 5% aqueous citric acid, and saturated aqueous NaHCO 3 (5 ml each), dried over MgSO 4 , and concentrated in vacuo, leaving a yellow glass. This was purified by column chromatography on silica gel (AcOEt) to give 26 (4.6 mg, 57%) as a faintly yellow glass, 1 ii) Compound 26 (4 mg, 0.004 mmol) was hydrogenated over Pearlman's catalyst (4 mg) in MeOH (2 ml) at 40°C for 2 h and then at 50°C for a further 2 h. The catalyst was filtered off and washed with hot MeOH (100 ml). The filtrate and washings were combined and concentrated in vacuo. with Bu 4 NF and purification of the product were performed in manners similar to those described above for the preparation of (aS,bR)-11, giving (aS,bS )-11 (19 mg, 86%) as a colorless glass. This was subjected to HPLC [LiChrosorb RP18 (7 mm, 250ϫ10 mm) (Merck); MeOH-H 2 O (30 : 70, v/v) at the rate of 1.5 ml/min] in seven portions to give (aS,bS )-11 · 3/2H 2 O (12 mg, 50%), mp 183-185°C. Recrystallization of this compound from 90% (v/v) aqueous MeOH, drying over P 2 O 5 at 2 mmHg and 50°C for 10 h, and exposure to air at room temperature until a constant weight was reached, provided an analytical sample of (aS,bS )-11 · 3/2H 2 3) and optically pure on the basis of chiral HPLC analysis.
16)
Hydrolysis of (a aS,b bS)-11 leading to (a aS,b bS)-2 Hydrolysis of (aS,bS)-11 · 3/2H 2 O (2.1 mg) and purification of the product were performed in manners similar to those described above for the preparation of (aS,bR)-2, providing (aS,bS )-2 · 1/2H 2 O (1.5 mg), mp 230-233°C (dec.) [lit.
3 Isolation of b b-Hydroxywybutine Unfractionated tRNA was obtained as described below according to the reported procedure. 27) Twenty female Wistar rats were decapitated and their livers (160 g) removed and quickly chilled in ice. Batches of 9 g were homogenized with 88% (v/v) aqueous phenol (14 ml) and Tris buffer [0.02 M (HOCH 2 ) 3 CNH 2 -HCl (pH 7.5) containing 1 M NaCl-0.5 mM ethylenediaminetetraacetic acid-0.01 M MgCl 2 ] (14 ml) in a homogenizer at high speed for 2-3 min. The combined homogenate was shaken at room temperature for 2 h and centrifuged (8000 rpm, 40 min) at 4°C. The precipitate was mixed with the Tris buffer (150 ml) and centrifuged. EtOH (1.4 l) was added to the combined supernatant (ca. 700 ml), and the whole was stored at 4°C overnight. The precipitate that separated was collected by centrifugation at 4°C and suspended in 0.3 M aqueous AcONa (140 ml). The mixture was stirred at room temperature for 10 min after the addition of Me 2 CHOH (56 ml) and centrifuged at 20°C. The precipitate was again treated with 0.3 M aqueous AcONa (80 ml) and Me 2 CHOH (40 ml), and the mixture was centrifuged at 20°C. The combined supernatant was cooled with ice for 1 h after the addition of Me 2 CHOH (130 ml), and the precipitate was collected by centrifugation. The precipitate thus obtained was washed successively with 67% (v/v) aqueous EtOH (containing 0.1 M NaCl-0.005 M MgCl 2 ), EtOH, and Et 2 O (10 ml each), and dried over P 2 O 5 under reduced pressure, giving crude tRNA (184 mg). A portion of this product (100 mg, 1000 A 260 units) was dissolved in H 2 O (15 ml), and the solution (pH 8.9) was brought to pH 2.9 by the addition of dilute aqueous HCl. The resulting mixture was stirred at 40°C for 16 h and centrifuged at 4°C. After the addition of EtOH (30 ml) the supernatant was centrifuged at 4°C. The supernatant was neutralized with NaHCO 3 , and the precipitate that resulted was removed by centrifugation at 4°C. The supernatant was concentrated in vacuo, and the residue was purified by TLC on silica gel [CHCl 3 Isolation and Identification of b b-Hydroxywybutosine Crude tRNA (1 g, 10000 A 260 units) was produced in five batches of 20 rats in a manner similar to that described above. This was extracted with a mixture of 0.3 M aqueous AcONa (75 ml) and Me 2 CHOH (30 ml) and then with a mixture of 0.3 M aqueous AcONa (42 ml) and Me 2 CHOH (21 ml). The extracts were combined, centrifuged, and diluted with Me 2 CHOH (70 ml). The resulting precipitate was collected by centrifugation at 4°C after cooling with ice, washed successively with EtOH and Et 2 O, and dried to give the first crop of tRNA (520 mg). The residue, which remained undissolved on extraction with a mixture of aqueous AcONa and Me 2 CHOH, was further extracted with 0.3 M aqueous AcONa (2ϫ28 ml). The extracts were collected by centrifugation, diluted with Me 2 CHOH (58 ml), and chilled with ice. The resulting precipitate was collected by centrifugation at 4°C, providing a second crop of tRNA (210 mg). These crops were combined and extracted twice with the Tris buffer (20 ml and 10 ml) described above. The extracts were collected by centrifugation at 20°C and subjected to a column packed with ion-exchange cellulose (Whatman DE 32) (wet volume 50 ml) which had been equilibrated with the Tris buffer. The column was washed with the Tris buffer (140 ml) followed by elution with the Tris buffer (800 ml) containing 1 M NaCl. EtOH (1.5 l) was added to the eluate and the mixture was stored at 4°C overnight. The resulting precipitate was collected by centrifugation at 4°C, washed successively with 67% (v/v) aqueous EtOH (containing 0.1 M NaCl-0.005 M MgCl 2 ), EtOH, and Et 2 O (30 ml each), and dried over P 2 O 5 under reduced pressure, providing tRNA (355 mg).
A portion of this product (350 mg, 5300 A 260 units) was treated with nuclease P 1 (Yamasa) (500 units) in 0.02 M acetate buffer (pH 5.35, 30 ml) at 50°C for 3 h. The hydrolysate was subjected to column chromatography on Cosmosil 140C 18 -OPN (Nacalai Tesque) (10 g) [H 2 O (80 ml) and then MeOH-H 2 O (30 : 70, v/v)] in two portions. The MeOH-H 2 O fractions (80 ml) were combined and concentrated in vacuo to leave a yellow glass (210 A 260 units). It was dissolved in H 2 O (3.9 ml), and a solution of nuclease P 1 (2000 units) in 0.02 M acetate buffer (pH 5.35, 4.7 ml) was added. The whole was stored at 50°C for 3 h and then 0.02 N aqueous NaOH (1.05 ml) and Escherichia coli alkaline phosphatase (Takara Shuzo) (6.4 units) were added. The mixture (pH 9) was stored at 50°C for 1 h and concentrated in vacuo. This was dissolved in H 2 O (8 ml) and purified by HPLC [LiChrosorb RP18 (7 mm, 250ϫ10 mm) (Merck); MeOH-H 2 O (30 : 70, v/v)] in seven portions, providing the target nucleoside (1.5 A 310 unit, ca. 100 mg), of which HPLC behavior was identical to that of (aS,bS )-11.
The nucleoside was dissolved in a mixture of Ac 2 O-d 6 (29 mg) and pyridine (69 mg), stored at room temperature for 1. 
